| Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes RM Bergenstal, WV Tamborlane, A Ahmann, JB Buse, G Dailey, SN Davis, ... New England Journal of Medicine 363 (4), 311-320, 2010 | 1194 | 2010 |
| A clinical trial to maintain glycemic control in youth with type 2 diabetes TODAY Study Group New England Journal of Medicine 366 (24), 2247-2256, 2012 | 1012 | 2012 |
| Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline KC Copeland, P Zeitler, M Geffner, C Guandalini, J Higgins, K Hirst, ... The Journal of Clinical Endocrinology & Metabolism 96 (1), 159-167, 2011 | 568 | 2011 |
| Racial-ethnic disparities in management and outcomes among children with type 1 diabetes SM Willi, KM Miller, LA DiMeglio, GJ Klingensmith, JH Simmons, ... Pediatrics 135 (3), 424-434, 2015 | 367 | 2015 |
| Neurocognitive deficits in morbidly obese children with obstructive sleep apnea SK Rhodes, KC Shimoda, LR Waid, PM O'Neil, MJ Oexmann, NA Collop, ... The Journal of pediatrics 127 (5), 741-744, 1995 | 356 | 1995 |
| Long-term treatment of osteopetrosis with recombinant human interferon gamma LL Key Jr, RM Rodriguiz, SM Willi, NM Wright, HC Hatcher, DR Eyre, ... New England Journal of Medicine 332 (24), 1594-1599, 1995 | 352 | 1995 |
| Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial LM Laffel, LG Kanapka, RW Beck, K Bergamo, MA Clements, A Criego, ... Jama 323 (23), 2388-2396, 2020 | 325 | 2020 |
| Racial Differences in the Relationship of Glucose Concentrations and Hemoglobin A1c Levels RM Bergenstal, RL Gal, CG Connor, R Gubitosi-Klug, D Kruger, BA Olson, ... Annals of internal medicine 167 (2), 95-102, 2017 | 313 | 2017 |
| Severe hypoglycemia and diabetic ketoacidosis among youth with type 1 diabetes in the T1D Exchange clinic registry E Cengiz, D Xing, JC Wong, JI Wolfsdorf, MW Haymond, A Rewers, ... Pediatric diabetes 14 (6), 447-454, 2013 | 300 | 2013 |
| Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients MR Rigby, KM Harris, A Pinckney, LA DiMeglio, MS Rendell, EI Felner, ... The Journal of clinical investigation 125 (8), 3285-3296, 2016 | 292 | 2016 |
| Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN) DR Weber, K Haynes, MB Leonard, SM Willi, MR Denburg Diabetes care 38 (10), 1913-1920, 2015 | 292 | 2015 |
| Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. G Argyropoulos, AM Brown, SM Willi, J Zhu, Y He, M Reitman, SM Gevao, ... The Journal of clinical investigation 102 (7), 1345-1351, 1998 | 272 | 1998 |
| Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control TD Riddlesworth, RW Beck, RL Gal, CG Connor, RM Bergenstal, S Lee, ... Diabetes technology & therapeutics 20 (4), 314-316, 2018 | 245 | 2018 |
| The effects of a high-protein, low-fat, ketogenic diet on adolescents with morbid obesity: body composition, blood chemistries, and sleep abnormalities SM Willi, MJ Oexmann, NM Wright, NA Collop, LL Key Jr Pediatrics 101 (1), 61-67, 1998 | 216 | 1998 |
| Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial MR Rigby, LA DiMeglio, MS Rendell, EI Felner, JM Dostou, SE Gitelman, ... The lancet Diabetes & endocrinology 1 (4), 284-294, 2013 | 197 | 2013 |
| Obesity in youth with type 1 diabetes in Germany, Austria, and the United States SN DuBose, JM Hermann, WV Tamborlane, RW Beck, A Dost, ... The Journal of pediatrics 167 (3), 627-632. e4, 2015 | 186 | 2015 |
| Effectiveness of sensor‐augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 study RH Slover, JB Welsh, A Criego, SA Weinzimer, SM Willi, MA Wood, ... Pediatric diabetes 13 (1), 6-11, 2012 | 168 | 2012 |
| Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial KC Herold, SE Gitelman, SM Willi, PA Gottlieb, F Waldron-Lynch, ... Diabetologia 56, 391-400, 2013 | 157 | 2013 |
| Racial-ethnic inequity in young adults with type 1 diabetes S Agarwal, LG Kanapka, JK Raymond, A Walker, A Gerard-Gonzalez, ... The Journal of Clinical Endocrinology & Metabolism 105 (8), e2960-e2969, 2020 | 154 | 2020 |
| Sensor-augmented pump therapy for A1C reduction (STAR 3) study: results from the 6-month continuation phase RM Bergenstal, WV Tamborlane, A Ahmann, JB Buse, G Dailey, SN Davis, ... Diabetes Care 34 (11), 2403-2405, 2011 | 154 | 2011 |
